NCT05058508 LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients
| NCT ID | NCT05058508 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wake Forest University Health Sciences |
| Condition | Pediatric Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-03-11 |
| Primary Completion | 2027-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-03-11 with a primary completion date of 2027-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to see if there are physical and emotional benefits to participating in a structured exercise regimen for those who are ages 2-25, are newly diagnosed with a blood or solid tumor cancer, and are currently undergoing or will begin cancer treatment.
Eligibility Criteria
Inclusion Criteria: 1. Ages 2-25 at time of consent 2. Subject has newly diagnosed cancer per Investigator, and is planning to undergo chemotherapy for treatment of malignancy for at least 3 full cycles 3. Ability of subject (and/or parent/guardian) to read and understand the English or Spanish language 4. As determined and documented by the enrolling investigator, ability of the subject to understand and comply with study procedures for the entire length of the study 5. Subject has newly diagnosed cancer per Investigator and is planning to undergo chemotherapy, immunotherapy, or other systemically delivered for treatment of malignancy. Subjects are allowed to be enrolled up to 21 days after initiating cancer treatment. 6. Receiving oncologic care at Levine Children's Cancer and Blood Disorders Clinic. 7. Subject is anticipated to receive at least 3 full cycles of chemotherapy or other systemic cancer treatment. 8. Not participating in another clinical trial that precludes participating in additional nondrug clinical trials. Exclusion Criteria: 1. Known cardiac dysfunction that, in the opinion of the investigator, would be unsafe for the child to participate in the exercise program 2. Any other uncontrolled intercurrent illness/medical condition or psychiatric illness/social situations that would limit compliance with study requirements or would be considered unsafe for the child to participate as determined by the Investigator. 3. Recent (within 4 weeks of enrollment) or planned surgery that will result in prolonged limited mobility not amendable to exercise modifications per investigator discretion 4. Primary CNS Tumor 5. Osteosarcoma
Contact & Investigator
Jennifer Pope, MD
PRINCIPAL INVESTIGATOR
Wake Forest University Health Sciences
Frequently Asked Questions
Who can join the NCT05058508 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 25 Years, studying Pediatric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05058508 currently recruiting?
Yes, NCT05058508 is actively recruiting participants. Contact the research team at Megan.Lattanze@advocatehealth.org for enrollment information.
Where is the NCT05058508 trial being conducted?
This trial is being conducted at Charlotte, United States.
Who is sponsoring the NCT05058508 clinical trial?
NCT05058508 is sponsored by Wake Forest University Health Sciences. The principal investigator is Jennifer Pope, MD at Wake Forest University Health Sciences. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.